| Literature DB >> 31867149 |
Fabian Hundemer1, Lorenz Graf von Reventlow2,3, Céline Leonhardt1, Mika Polamo4, Martin Nieger4, Stefan M Seifermann1, Alexander Colsmann2,3, Stefan Bräse1,3,5.
Abstract
We demonstrate modular modifications of the widely employed emitter 2,4,5,6-tetra(9H-carbazol-9-yl)isophthalonitrile (4CzIPN) by replacing one or both nitrile acceptors with oxadiazole groups via a tetrazole intermediate. This allows the introduction of various functional groups including halides, alkynes, alkenes, nitriles, esters, ethers and a protected amino acid while preserving the thermally activated delayed fluorescence (TADF) properties. The substituents control the emission maximum of the corresponding emitters, ranging between 472-527 nm, and show high solid-state photoluminescence quantum yields up to 85 %. The TADF emission of two compounds, 4CzCNOXDtBu and 4CzdOXDtBu, a mono- and a bis-oxadiazole substituted 4CzIPN is characterized in detail by time- and temperature-dependent photoluminescence. Solution-processed OLEDs comprising 4CzCNOXDtBu and 4CzdOXDtBu show a significant blue-shift of the emission compared to the reference 4CzIPN, with external quantum efficiencies of 16 %, 5.9 % and 17 % at 100 cd m-2, respectively. ©2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA.Entities:
Keywords: color-tuning; functionalization; organic light emitting diodes (OLED); oxadiazoles; thermally activated delayed fluorescence
Year: 2019 PMID: 31867149 PMCID: PMC6909881 DOI: 10.1002/open.201900141
Source DB: PubMed Journal: ChemistryOpen ISSN: 2191-1363 Impact factor: 2.911
Scheme 1Synthesis of mono‐oxadiazole derivatives of 4CzIPN in a two‐step protocol. a: reaction starting from the respective carboxylic acid.
Scheme 2Synthesis of the bis‐oxadiazole derivatives of 4CzIPN following a two‐step protocol.
Figure 1Molecular structure of a) 4CzCNOXDMe, b) 4CzCNOXD2,6OMePh, c) 4CzCNOXDMes and d) 4CzCNOXDC6F5 – (minor disordered parts were omitted for clarity, displacement parameters are drawn at 50 % probability level).
Figure 2DFT calculations of a) 4CzIPN, b) the mono‐oxadiazole derivative 4CzCNOXDtBu and c) the bis‐oxadiazole derivative 4CzdOXDtBu.
Figure 3Emission spectra of selected mono‐ and bis‐oxadiazole derivatives of 4CzIPN.
Figure 4a) Photoluminescence decay of compounds 3 a and 5 a in mCP at room temperature. The samples were excited at 340 nm and the PL‐decays were measured at 500 nm (3 a) and 480 nm (5 a). b) Arrhenius plot of the RISC rate over the inverse temperature and calculation of the TADF activation energy. c,d) Temperature dependent PLQY and delayed fluorescence component of 5 a and 4CzIPN in mCP. e,f) Emission spectra of compound 3 a and 5 a after 1.6 ns, 30.5 ns and 1–10 μs as well as the steady‐state emission spectrum.
Figure 5a) J−V (left axis) and L−V characteristics (right axis) of solution processed OLEDs containing either of the emitters 4CzIPN, 3 a and 5 a. b) Current efficiency. Inset: photos of OLEDs containing 4CzIPN, 3 a and 5 a (from left to right). The color shift is clearly visible. c) Efficacy and d) EQE. All graphs represent the second measurement of the devices, and the current densities were kept moderate to prevent degradation of the OLEDs during the measurements.